Doctor Cleared After Euthanizing 2-Year-Old

newborn baby sleeping in a parent's arms
Photo: KieferPix / Shutterstock

When a country authorizes physicians, in rare circumstances, to deliberately end the life of a child who cannot consent, the center of gravity in end-of-life law shifts from personal autonomy to state-supervised assessments of suffering; that pivot is precisely what the Netherlands has now operationalized for ages 1 to 12, and the first reviewed case shows how the machinery works—and why it will remain fiercely contested.

At a Glance

  • The Dutch review committee for cases involving newborns and children 1–12 found a physician acted with due care in the first reported under‑12 euthanasia.
  • The framework requires unbearable suffering with no prospect of improvement, no reasonable alternatives, parental agreement, and independent review.
  • Health authorities transmitted the committee’s assessment to the Public Prosecution Service for the standard legal check that follows such cases.
  • Critics argue the child could not consent and that physicians disagreed about alternatives, highlighting a deep ethical rift that law cannot fully resolve.

What the Dutch system actually authorized—and why

The Netherlands built pediatric end‑of‑life rules in layers. Since 2002, minors aged 12 and up who are deemed decision‑competent may request euthanasia under the same core criteria as adults. Neonatal cases, by contrast, evolved through the Groningen Protocol, an extra‑statutory set of criteria for life‑ending acts in newborns with catastrophic conditions reviewed after the fact. In 2024, regulators added a narrow pathway for children aged 1 to 12: a doctor may end life only if suffering is judged unbearable and without prospect of improvement, no reasonable palliative or therapeutic alternative exists, the parents agree, and an independent physician concurs; a specialized committee then examines the case and reports its assessment to prosecutors for a legal review with potential consequences for the physician if safeguards were breached.

This is not a general entitlement; it is an exception carved into criminal law’s hard surface, designed to shield physicians from prosecution only when predefined criteria and process are met. The procedural backbone is deliberate: the independent consultation, rigorous documentation, and post‑hoc scrutiny by a standing review body are intended to replace the missing element that undergirds adult euthanasia—patient autonomy—with multi‑layered professional and state oversight.

The first under‑12 case reviewed: what the record supports

In the first reported application of the 1–12 framework, the Dutch Review Committee for Late Termination of Pregnancy and Termination of Life in Newborns and Children concluded the attending physician acted with due care. The Health Minister confirmed in a legal letter to parliament that the case was examined and that the assessment would be forwarded to the Public Prosecution Service (OM), following the established pathway in which prosecutors can determine whether to proceed or decline based on the committee’s findings.

Secondary reporting of the committee’s conclusions describes a two‑year‑old with severe, irreversible neurological injury—cerebral palsy, refractory epilepsy, and profound impairment of motor function and behavior—coupled with breathing, swallowing, and sleeping problems. The committee reportedly determined there was no prospect of improvement and that prior attempts at symptom control, including alternative medication and palliative measures, had failed or produced additional burdensome side effects, leaving no reasonable alternative to alleviate suffering within the child’s lifespan. Those claims track the framework’s legal predicates: intolerable, unrelievable suffering and futility of alternatives under expert review.

Due care in practice: process, not slogans

In systems like the Dutch model, “due care” is not an abstraction; it is a checklist embedded in law and professional guidance. It includes an explicit diagnosis and prognosis, assessment of suffering’s intensity and persistence, a documented exploration of treatments and palliative options, an independent physician’s written opinion, and informed parental agreement—followed by committee review that can trigger prosecutorial action if the physician deviated. The NL Times reporting indicates the committee spoke directly with the physician before finalizing its view and transmitting its assessment to the OM, which is consistent with that mandate. The committee’s remit is not to moralize but to evaluate whether the concrete statutory and professional criteria were, in fact, satisfied.

Because pediatric cases below the age of consent hinge on judgments about suffering and benefit, they demand methodical documentation of alternatives tried, reasons for futility, and proportionality of burdens—a clinical ethics discipline as much as a legal one. The first case’s reported dossier reflects that architecture: a trajectory of severe neurological impairment, attempts at control, adverse effects, and a prognosis devoid of realistic improvement.

Where the disagreement truly lies

Objections fall into two categories. The first is procedural: some physicians reportedly believed that alternatives remained or that suffering was not demonstrably continuous and unbearable—claims that, if substantiated in the formal record, would directly contest the “no reasonable alternative” criterion. These objections surface in advocacy‑aligned outlets quoting unnamed clinicians; they are not accompanied by primary medical opinions or case identifiers in the public domain, which limits independent verification of the counter‑claims against the committee’s review.

The second is moral and conceptual: critics argue that euthanizing a non‑consenting, disabled child is categorically wrong and that suffering assessments are inherently subjective. This line of argument rejects the entire architecture of pediatric euthanasia, whether neonatal or 1–12, on grounds ranging from autonomy (the child cannot choose) to slippery‑slope concerns documented for decades in bioethics debates about the Dutch experience. Those arguments are coherent, serious, and longstanding—but they do not, by themselves, refute whether the specific case met the existing Dutch legal criteria; they reject the criteria.

Opacity, trust, and the limits of anonymized accountability

Anonymization protects families and clinicians, but it also weakens public trust. The absence of a publicly released case file, redacted medical records, or the independent consultant’s formal opinion means the debate defaults to institutional assurances on one side and principled denunciations on the other. That is the credibility gap endemic to rare pediatric end‑of‑life cases: the facts are sensitive enough to hide but consequential enough to demand scrutiny. The Dutch pathway mitigates this with a prosecutorial check—committee assessments go to the OM—but unless declinations or prosecutions are explained in detail, the public must largely infer compliance from the absence of sanction.

This is where aggregate transparency matters. Regular publication of anonymized case summaries, clear statements of prosecutorial outcomes, and longitudinal data on indications, alternatives attempted, and independent‑opinion content can demonstrate that “due care” is not a rubber stamp. Without that, opponents will plausibly characterize the process as subjective and permissive, regardless of the clinicians’ diligence.

What this means going forward

The under‑12 framework relocates the ethical fulcrum from autonomy to best‑interests judgments regulated by state procedure. In practical terms, that raises the bar for documentation and independent review far higher than in adult cases; it also raises the stakes of disagreement among professionals. If future cases show consistent prosecutorial concurrence with the committee, the model will be seen—by its proponents—as a disciplined, narrow safety valve for extreme suffering, and—by critics—as normalization of nonvoluntary life‑ending for disability. Both readings can be true to their premises.

Sources:

lifesitenews.com, billygraham.org, lifenews.com, familycouncil.org, nltimes.nl, novanews.co.za

© integritytimes.com 2026. All rights reserved.